← Eichor
Study identifier: NCT05718440 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Uronephrological Complications Risk Factors in Spinal Dysraphism

Condition: Spinal Dysraphism  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Spinal dysraphism consist of congenital malformations resulting of abnormalities in the formation of neural tube and/or surrounding structures during embryogenesis. The aim of this study is to assess if there are specific clinical and paraclinical patterns of pelvic (urinary, bowel, sexual) disorders depending on the dysraphism's type and level of injury. This description will help to determine a prognosis on symptoms and the risk of complication depending on the dysraphism's type and level of injury. It will provide targeted evaluation and cares: identifying patients who will be at risk of complications and needing acute monitoring or preventing cares on the symptoms' onset. Pelvic disorders have an important impact on morbi-mortality (urinary dysfunction is the first cause of mortality in adults by renal failure or infection) and also on patients' quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Maelys Teng, MD, MSc  ·  0156017954  ·  maelys.teng@aphp.fr

Claire Hentzen, MD, MSc  ·  0156017954  ·  claire.hentzen@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Tenon hospitalParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05718440